Article/Report  |   October 2006
Alterations in CNS Activity Induced by Botulinum Toxin Treatment in Spasmodic Dysphonia: An H215O PET Study
 
Author Notes
  • Contact author: Allen R. Braun, Language Section, Voice, Speech and Language Branch, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Building 10, Room 8S235A, 10 Center Drive, Bethesda, MD 20892. E-mail: brauna@nidcd.nih.gov
  • © 2006 American Speech-Language-Hearing AssociationAmerican Speech-Language-Hearing Association
Article Information
Speech, Voice & Prosodic Disorders / Voice Disorders / Telepractice & Computer-Based Approaches / Speech, Voice & Prosody / Speech
Article/Report   |   October 2006
Alterations in CNS Activity Induced by Botulinum Toxin Treatment in Spasmodic Dysphonia: An H215O PET Study
Journal of Speech, Language, and Hearing Research, October 2006, Vol. 49, 1127-1146. doi:10.1044/1092-4388(2006/081)
History: Received February 10, 2005 , Accepted March 1, 2006
 
Journal of Speech, Language, and Hearing Research, October 2006, Vol. 49, 1127-1146. doi:10.1044/1092-4388(2006/081)
History: Received February 10, 2005; Accepted March 1, 2006
Web of Science® Times Cited: 18

Speech-related changes in regional cerebral blood flow (rCBF) were measured using H215O positron-emission tomography in 9 adults with adductor spasmodic dysphonia (ADSD) before and after botulinum toxin (BTX) injection and 10 age- and gender-matched volunteers without neurological disorders. Scans were acquired at rest and during production of continuous narrative speech and whispered speech. Speech was recorded during scan acquisition for offline quantification of voice breaks, pitch breaks, and percentage aperiodicity to assess correlations between treatment-related changes in rCBF and clinical improvement. Results demonstrated that speech-related responses in heteromodal sensory areas were significantly reduced in persons with ADSD, compared with volunteers, before the administration of BTX. Three to 4 weeks after BTX injection, speech-related responses were significantly augmented in these regions and in left hemisphere motor areas commonly associated with oral-laryngeal motor control. This pattern of responses was most strongly correlated with the objective measures of clinical improvement (decreases in the frequency of voice breaks, pitch breaks, and percentage aperiodicity). These data suggest a pathophysiological model for ADSD in which BTX treatment results in more efficient cortical processing of sensory information, making this information available to motor areas that use it to more effectively regulate laryngeal movements.

Acknowledgments
This research was presented at the 31st Annual Meeting of the Society for Neuroscience, San Diego, CA, November 13, 2001. We thank the participants in this study and the National Institutes of Health Clinical Center Positron Emission Tomography Department personnel for their assistance with this work.
Order a Subscription
Pay Per View
Entire Journal of Speech, Language, and Hearing Research content & archive
24-hour access
This Article
24-hour access